Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Johann

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Oncotarget|December 10, 2015
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumorSomayyeh Fahiminiya, Leora Witkowski, Javad Nadaf, et al.
Klinische Padiatrie|June 24, 2026
Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study GroupPascal Johann, Dominik Sturm, Rolf Kortmann, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.
Cancer Communications (London, England)|November 2, 2025
In vivo intratumoral heterogeneity in a dish: scalable forebrain organoid models of embryonal brain tumors for high-throughput personalized drug discoveryNicole C Riedel, Carolin Walter, Flavia W de Faria, et al.
Nature Communications|March 23, 2022
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumorsMonika Graf, Marta Interlandi, Natalia Moreno, et al.
Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|November 2, 2020
Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Human Reproduction (Oxford, England)|August 8, 2023
Rhabdoid tumors in patients conceived following ART: is there an association?Karolina Nemes, Martin Benesch, Julia Kolarova, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Oncotarget|December 10, 2015
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumorSomayyeh Fahiminiya, Leora Witkowski, Javad Nadaf, et al.
Klinische Padiatrie|June 24, 2026
Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study GroupPascal Johann, Dominik Sturm, Rolf Kortmann, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.
Cancer Communications (London, England)|November 2, 2025
In vivo intratumoral heterogeneity in a dish: scalable forebrain organoid models of embryonal brain tumors for high-throughput personalized drug discoveryNicole C Riedel, Carolin Walter, Flavia W de Faria, et al.
Nature Communications|March 23, 2022
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumorsMonika Graf, Marta Interlandi, Natalia Moreno, et al.
Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.
Neuro-Oncology|October 4, 2021
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocolMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Neuro-Oncology|November 2, 2020
Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.
Human Reproduction (Oxford, England)|August 8, 2023
Rhabdoid tumors in patients conceived following ART: is there an association?Karolina Nemes, Martin Benesch, Julia Kolarova, et al.
Pageof 3